Third-generation smallpox vaccines induce low-level cross-protecting neutralizing antibodies against Monkeypox virus in laboratory workers.

Heliyon · 2024 · PMC11141380 · PMID 38826712

Europe PMC DOI

hedged sentence

0.0513

closest p · 1.0× alpha

0.0513

boldest claim

The sentences

showed a trendp = 0.0513so close (0.05 < p ≤ 0.1)

However, the first-generation vaccine recipients showed a trend towards higher IgG levels compared to negative controls (p = 0.0513, ns, Fig. 4 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.